Orphan Development Capabilities | Why Catalent?

Summary: Accelerated regulatory pathways of fast track and breakthrough designations can often shave years off the approval process. Accelerating the development and approval of many drugs is often in everyone’s interest, especially when the drug in question is to treat a rare or life-threatening disease. We have integrated solutions from development to commercialization and in-house efficiencies to help ensure your project success.